FDA Adverse Event Injury Summary report: N

ALAIR BRONCHIAL THERMOPLASTY CATHETER

MDR report key: 3140381 · Received May 31, 2013

Report

Report Number
3005099803-2013-04417
Event Type
Injury
Date Received
May 31, 2013
Date of Event
April 30, 2013
Report Date
May 3, 2013
Manufacturer
BOSTON SCIENTIFIC - SAN JOSE
Product Code
OOY
PMA / PMN Number
P080032
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

PATIENT IDENTIFIER: (B)(6). PATIENT WEIGHT: (B)(6). (B)(4). THE COMPLAINANT INDICATED THAT THE DEVICE HAS BEEN DISPOSED AND WILL NOT BE RETURNED FOR EVALUATION; THEREFORE A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. IF ANY FURTHER RELEVANT INFORMATION IS IDENTIFIED, A SUPPLEMENTAL MEDWATCH WILL BE FILED.

Description of Event or Problem · 1

IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT AN ALAIR BRONCHIAL THERMOPLASTY CATHETER WAS USED DURING A BRONCHIAL THERMOPLASTY (BT) PROCEDURE ON (B)(6) 2013 AS PART OF THE (B)(4) STUDY. ACCORDING TO THE COMPLAINANT, THE PATIENT UNDERWENT HER FIRST BT TREATMENT TO THE RIGHT LOWER LOBE. THE PROCEDURE WAS SUCCESSFULLY COMPLETED WITH NO ISSUES NOTED. FOLLOWING THE PROCEDURE, THE PATIENT EXPERIENCED AN EVENT OF ASTHMA AGGRAVATION. THE PATIENT DEVELOPED A WHEEZE POST BT TREATMENT AND WAS HOSPITALIZED. DURING HER HOSPITALIZATION, SHE WAS TREATED WITH INTRAVENOUS SOLU-MEDROL. ON (B)(6) 2013, THE PATIENT WAS DISCHARGED FROM THE HOSPITAL. ON (B)(6) 2013, THE EVENT OF ASTHMA AGGRAVATION WAS REPORTED TO BE RESOLVED. BASELINE SPIROMETRY VALUES: VISIT DATE: (B)(4) 2013. PRE-BRONCHODILATOR: FEV1: 2.22; FEV1 % PREDICTED: 90.24; FVC: 2.48; FVC % PREDICTED: 80.52. POST-BRONCHODILATOR: FEV1: 2.26; FEV1 % PREDICTED: 91.87; FVC: 2.54; FVC % PREDICTED: 82.47.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
241562 ALAIR BRONCHIAL THERMOPLASTY CATHETER ELECTROSURGICAL, BRONCHIAL THERMOPLASTY CATHETER & SYSTEM & ACCESSORIES OOY BOSTON SCIENTIFIC - SAN JOSE M005ATS25010 CM-061812-024

Patients

Seq Age Sex Outcome Treatment
1 48 YR Hospitalization